{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:10:22Z","timestamp":1787069422942,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["H2018001"],"award-info":[{"award-number":["H2018001"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2572018BU03"],"award-info":[{"award-number":["2572018BU03"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004027","name":"Heilongjiang Postdoctoral","doi-asserted-by":"publisher","award":["LBH-Z10282"],"award-info":[{"award-number":["LBH-Z10282"]}],"id":[{"id":"10.13039\/501100004027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bulcan.2023.02.007","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T09:33:11Z","timestamp":1678095191000},"page":"478-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Synergistic effect of docetaxel and gambogic acid on bone metastasis of lung cancer"],"prefix":"10.1016","volume":"110","author":[{"given":"Siyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-9600","authenticated-orcid":false,"given":"Shougang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2023.02.007_bib0130","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.21037\/tlcr-20-835","article-title":"Current progress and mechanisms of bone metastasis in lung cancer: a narrative review","volume":"10","author":"Wu","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12885-017-3922-0","article-title":"Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States","volume":"18","author":"Hernandez","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0145","doi-asserted-by":"crossref","first-page":"e016022","DOI":"10.1136\/bmjopen-2017-016022","article-title":"Survival after bone metastasis by primary cancer type: a Danish population-based cohort study","volume":"7","author":"Svensson","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0150","doi-asserted-by":"crossref","first-page":"115492","DOI":"10.1016\/j.bone.2020.115492","article-title":"Targeting anti-cancer agents to bone using bisphosphonates","volume":"138","author":"Xing","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2019.01.01","article-title":"Chinese guidelines for diagnosis and treatment of primary lung cancer 2018 (English version)","volume":"31","year":"2019","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ctrv.2016.09.013","article-title":"Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials","volume":"50","author":"LeVasseur","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0165","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/acs.jnatprod.7b01012","article-title":"Quest for efficacious next-generation taxoid anticancer agents and their tumor-targeted delivery","volume":"81","author":"Ojima","year":"2018","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0170","first-page":"4","article-title":"Historical evolution of second-line therapy in non-small cell lung","volume":"4","author":"Lazzari","year":"2017","journal-title":"Cancer Front Med (Lausanne)"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0175","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/cas.12448","article-title":"Phase II study of zoledronic acid combined with docetaxel for non-small-cell lung cancer: West Japan Oncology Group","volume":"105","author":"Murakami","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0180","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.3747\/co.21.1997","article-title":"Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer","volume":"21","author":"Socinski","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0185","first-page":"293","article-title":"[Progress in research of the structural optimization of natural product-like Garcinia caged xanthones]","volume":"49","author":"Wang","year":"2014","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.celrep.2012.11.023","article-title":"Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo","volume":"3","author":"Li","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0195","doi-asserted-by":"crossref","first-page":"10385","DOI":"10.2147\/IJN.S277645","article-title":"Gambogic acid as a candidate for cancer therapy: a review","volume":"15","author":"Liu","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0200","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BJ20150151","article-title":"Gambogic acid inhibits osteoclast formation and ovariectomy-induced osteoporosis by suppressing the JNK, p38 and Akt signalling pathways","volume":"469","author":"Ma","year":"2015","journal-title":"Biochem J"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0205","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3760\/cma.j.issn.0366-6999.20122582","article-title":"An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors","volume":"126","author":"Chi","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1472-6882-12-58","article-title":"Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines","volume":"12","author":"Zou","year":"2012","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0215","doi-asserted-by":"crossref","first-page":"119558","DOI":"10.1016\/j.biomaterials.2019.119558","article-title":"Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis","volume":"227","author":"Vijayaraghavalu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0220","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1080\/10428190802353591","article-title":"Preclinical versus clinical drug combination studies","volume":"49","author":"Chou","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0225","first-page":"542","article-title":"Docetaxel-loaded bovine serum albumin nanoparticles conjugated docosahexaenoic acid for inhibiting lung cancer metastasis to bone anticancer agents","volume":"17","author":"Zu","year":"2017","journal-title":"Med Chem"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0230","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","article-title":"Progression and metastasis of lung cancer","volume":"35","author":"Popper","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3892\/mco.2016.917","article-title":"Progress in the research on the mechanism of bone metastasis in lung cancer","volume":"5","author":"Luo","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.actbio.2017.12.028","article-title":"Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA","volume":"68","author":"Kang","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0245","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3892\/ol.2015.3599","article-title":"Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFR-T790M mutant lung cancer","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bulcan.2023.02.007_bib0250","doi-asserted-by":"crossref","first-page":"173486","DOI":"10.1016\/j.ejphar.2020.173486","article-title":"Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer","volume":"888","author":"Hatami","year":"2020","journal-title":"Eur J Pharmacol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:20:38Z","timestamp":1762104038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455123000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0007455123000942"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.02.007","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effect of docetaxel and gambogic acid on bone metastasis of lung cancer","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}